Clinical trial
Oxford Classification and Clinical Remission After Initial Treatments in Patients With IgA Nephropathy:a Cohort Study
NCT05528991 is registered in ClinicalTrials.gov with Shenzhen Second People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Oxford Classification and Clinical Remission After Initial Treatments in Patients With IgA Nephropathy:a Cohort Study
- Lead sponsor
- Shenzhen Second People's Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 1, 2022
- Completion date
- June 30, 2025
- Enrollment
- 474 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
iga nephropathy